Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease
Vascular endothelial growth factor A (VEGF-A) is a prominent pro-angiogenic and pro-permeability factor in the kidney. Alternative splicing of the terminal exon of VEGF-A through the use of an alternative 3′ splice site gives rise to a functionally different family of isoforms, termed VEGF-Axxxb, kn...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2018-02-01
|
| Series: | Genes |
| Subjects: | |
| Online Access: | http://www.mdpi.com/2073-4425/9/2/98 |